SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 3, 1998
DERMA SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 1-31070 23-2328753
(State or other jurisdiction (Commission (IRS employer
of incorporation) File Number) identification number)
214 Carnegie Center, Suite 100
Princeton, NJ 08540
(609) 514-4744
(Address including zip code and telephone
number, of principal executive offices)
<PAGE>
ITEM 5. OTHER EVENTS
Mr. Srini Conjeevaram was appointed to the Board of Directors of the
Registrant on April 3, 1998. He has also been appointed to the Compensation and
Audit Committees of the Board of Directors.
Incorporated by reference is the press release issued April 14, 1998
concerning the Registrant's announcement of the appointment of Srini Conjeevaram
to its Board of Directors, attached hereto as Exhibit 99.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Not applicable
(b) Not applicable
(c) Exhibits:
Number Description
------ -----------
99 Press release issued April 14, 1998.
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
DERMA SCIENCES, INC.
Date: April 14, 1998 By:/s/ Edward J. Quilty
---------------------
Edward J. Quilty
Chairman
DERMA SCIENCES
- --------------
News Release
FOR RELEASE APRIL 14, 1998 AT 7:30AM EDT
- ----------------------------------------
Contact: Allen & Caron Inc. or Edward J. Quilty, Chairman
Mark Alvino (Investors) Derma Sciences, Inc.
212-698-1360 609-514-4744
Owen Daley (media)
714-252-8440
SRINI CONJEEVARAM APPOINTED TO DERMA SCIENCES BOARD
PRINCETON, NJ (April 14, 1998)...Derma Sciences, Inc. (Nasdaq:DSCI) announced
today that Srini Conjeevaram, 39, an experienced finance executive, has been
appointed to its Board of Directors. Conjeevaram is currently a General Partner
and the Chief Financial Officer of Galen Associates, a healthcare venture
capital firm, and also serves as a Director of Halsey Drug Company (AMEX:HDG).
Prior to his affiliation with Galen Associates, he was in Corporate Finance at
Smith Barney.
Derma Sciences Chairman Edward J. Quilty commented, "Srini Conjeevaram
brings to the Board a significant collection of senior executive experience in
healthcare financing and an engineer's operations-oriented and
implementation-oriented approach to business. He will add measureably to the
Board's resources, and the management and Directors of Derma Sciences look
forward to calling on Srini's experience and insight as the Company builds for
the future."
Conjeevaram graduated from Madras University, Madras, India. He received
a Master of Science degree in Mechanical Engineering from Stanford University
and a Master of Business Administration in Finance from Indiana University. He
resides with his wife in Bronxville, N.Y.
Derma Sciences, Inc is engaged in the development, marketing and sales
of topical nutrient-based would care products using its proprietary zinc
formulation for the management of certain chronic, non-healing skin ulcerations
such as pressure and venous ulcers, surgical incisions and burns. For more
information about Derma Sciences, Inc., visit its home page on the Internet at
http://www.dermasciences.com.
